ON
BeOne Medicines, Ltd. American Depositary Receipt (ONC)
NASDAQ
371.98
-2.49 (-0.66%)
Closed
Aug 24, 2026
Day's Range
365.14372.73
52 wk Range
253.95385.22
Financial Statements - ONC - BeOne Medicines, Ltd. American Depositary Receipt
Revenue
5.34B▲ 40.2%
Net Income
286.93M▲ 144.5%Net Margin 5.4%
EBITDA
616.77M▲ 255.6%
Free Cash Flow
861.05M▲ 228.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 5.34B | 3.81B | 2.45B | 1.41B | 1.17B | 308.87M |
| Cost of Goods | 668.54M | 594.08M | 379.92M | 286.47M | 164.90M | 70.65M |
| Gross Profit | 4.67B | 3.21B | 2.07B | 1.12B | 1.01B | 238.21M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 447.13M | -568.19M | -1.20B | -1.78B | -1.43B | -1.65B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -42.55M | -12.63M | 307.89M | -223.85M | 15.90M | 37.49M |
| Pre Tax Income | 416.85M | -533M | -825.83M | -1.96B | -1.43B | -1.61B |
| Income Tax | 129.92M | 111.78M | 55.87M | 42.77M | 19.22M | 10.39M |
| Net Income | 286.93M | -644.78M | -881.70M | -2B | -1.45B | -1.62B |
| EPS Basic | 2.6 | -6.11 | -8.45 | -19.37 | -15.73 | -19.5 |
| EPS Diluted | 2.47 | -6.124009 | -8.45 | -19.37 | -15.73 | -19.5 |
| Basic Shares Outstanding | 109.06M | 105.28M | 104.38M | 103.13M | 92.78M | 83.47M |
| Diluted Shares Outstanding | 109.06M | 105.28M | 104.38M | 103.13M | 92.78M | 83.47M |
| Ebit | 475.08M | -568.19M | -1.20B | -1.78B | -1.43B | -1.65B |
| Ebitda | 616.77M | -396.43M | -1.12B | -1.72B | -1.39B | -1.62B |
| Net Income Continuous Operations | 286.93M | -644.78M | -881.70M | -2B | -1.45B | -1.62B |
| Minority Interests | - | - | - | 0 | 0 | 3.61M |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
